Interestingly, the more sensitive whole genome sequencing studies can detect more sub clonal mutations and reveal a much higher percentage (47–90%) of osteosarcomas harbouring TP53 alterations [3, 36–38, 45]. Here, TP53 is linked to osteosarcoma.